Israel Chemicals Shs (NYSE:ICL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Other equities research analysts have also issued research reports about the company. BidaskClub raised Israel Chemicals Shs from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. ValuEngine upgraded Israel Chemicals Shs from a “hold” rating to a “buy” rating in a report on Saturday, June 17th. Jefferies Group LLC restated a “hold” rating and set a $5.25 price target (up previously from $4.75) on shares of Israel Chemicals Shs in a report on Friday. Finally, BMO Capital Markets restated a “hold” rating and set a $4.50 price target on shares of Israel Chemicals Shs in a report on Wednesday, April 5th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $4.67.

Israel Chemicals Shs (NYSE ICL) traded down 2.28% on Monday, hitting $4.72. The company had a trading volume of 118,652 shares. The stock’s market capitalization is $6.02 billion. The stock has a 50 day moving average of $4.36 and a 200-day moving average of $4.34. Israel Chemicals Shs has a one year low of $3.52 and a one year high of $4.85.

Israel Chemicals Shs (NYSE:ICL) last posted its quarterly earnings data on Wednesday, May 10th. The basic materials company reported $0.05 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by $0.01. The business had revenue of $1.30 billion for the quarter, compared to the consensus estimate of $1.30 billion. Israel Chemicals Shs had a negative net margin of 2.23% and a positive return on equity of 15.39%. Israel Chemicals Shs’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.07 EPS. Equities analysts anticipate that Israel Chemicals Shs will post $0.30 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Israel Chemicals Shs (NYSE:ICL) Rating Increased to Hold at Zacks Investment Research” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/17/israel-chemicals-shs-nyseicl-rating-increased-to-hold-at-zacks-investment-research.html.

Several large investors have recently bought and sold shares of ICL. Goldman Sachs Group Inc. raised its stake in shares of Israel Chemicals Shs by 19.3% in the first quarter. Goldman Sachs Group Inc. now owns 10,041,116 shares of the basic materials company’s stock worth $42,775,000 after buying an additional 1,625,213 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Israel Chemicals Shs by 4.6% in the first quarter. Vanguard Group Inc. now owns 9,871,468 shares of the basic materials company’s stock worth $42,052,000 after buying an additional 434,474 shares during the last quarter. Norges Bank purchased a new position in shares of Israel Chemicals Shs during the fourth quarter worth $21,305,000. Bank of New York Mellon Corp raised its position in shares of Israel Chemicals Shs by 10.4% in the first quarter. Bank of New York Mellon Corp now owns 1,520,221 shares of the basic materials company’s stock worth $6,476,000 after buying an additional 143,262 shares during the last quarter. Finally, Parametric Portfolio Associates LLC raised its position in shares of Israel Chemicals Shs by 4.0% in the first quarter. Parametric Portfolio Associates LLC now owns 1,229,798 shares of the basic materials company’s stock worth $5,239,000 after buying an additional 47,860 shares during the last quarter. Hedge funds and other institutional investors own 5.97% of the company’s stock.

Get a free copy of the Zacks research report on Israel Chemicals Shs (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Shs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals Shs and related companies with MarketBeat.com's FREE daily email newsletter.